4729:2-3-04. Dispensing of naloxone by pharmacy interns  


Latest version.
  • (A) A pharmacy intern under the direct supervision of a pharmacist may dispense naloxone without a prescription to either of the following in accordance with an approved protocol specified in paragraph (B) of rule 4729:1-3-04 of the Administrative Code:

    (1) An individual who there is reason to believe is experiencing or at risk of experiencing an opioid-related overdose;

    (2) A family member, friend, or other person in a position to assist an individual who there is reason to believe is at risk of experiencing an opioid-related overdose.

    (B) A pharmacy intern under the direct supervision of a pharmacist who dispenses naloxone pursuant to this rule shall instruct the individual to whom naloxone is dispensed verbally or in writing to summon emergency services as soon as practicable either before or after administering naloxone.

    (C) Except as provided in paragraph (D) this rule, a pharmacy intern shall provide in-person training, unless the in-person requirement is waived by the board, and written educational materials to the individual to whom naloxone is dispensed that includes all the following:

    (1) Risk factors of opioid overdose;

    (2) Strategies to prevent opioid overdose;

    (3) Signs of opioid overdose;

    (4) Steps in responding to an overdose;

    (5) Information on the naloxone dispensed;

    (6) Procedures for administering the naloxone dispensed;

    (7) Proper storage and expiration of the naloxone dispensed; and

    (8) Information on where to obtain a referral for substance abuse treatment.

    (D) Patient training as required by paragraph (C) of this rule is not required if the patient has previously received training and all the following apply:

    (1) The patient is offered training and refuses;

    (2) The pharmacy intern has documentation confirming training pursuant to this rule has been provided within the previous twelve months;

    (3) A pharmacy intern under the direct supervision of a pharmacist who dispenses naloxone pursuant to this rule shall still instruct the individual to whom naloxone is dispensed verbally or in writing to summon emergency services as soon as practicable either before or after administering naloxone.

    (E) A terminal distributor of dangerous drugs shall ensure that all pharmacy interns that dispense naloxone pursuant to this rule are trained on the use of naloxone and can meet the training requirements listed in paragraphs (B) and (C) of this rule.


Effective: 12/1/2020
Five Year Review (FYR) Dates: 12/01/2025
Promulgated Under: 119.03
Statutory Authority: 3719.28, 4729.26
Rule Amplifies: 4729.44, 4729.41